Canada Digestive System Disorder Medicine Sales is set to reach $4,170 Million by 2026 from $3,860 Million 2021, jumped by 6% per year. Since 2017, the market was up 3.9% year on year at $36,680 Million. The country was number 4 in 2021, South Korea came ahead $3,860 Million. Japan, South Korea and Canada respectively came in numbers 2, 3 and 4 in this ranking.
How does Canada rank in Alimentary Tract and Metabolism Medicine Sales?
| # | 9 Countries | Million US Dollars | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 Canada | 5,850 | 2023 | +9.88% | +12.08% | |
| 2 | 2 Japan | 4,940 | 2023 | +0.079% | +7.75% | View data |
| 3 | 3 United Kingdom | 2,720 | 2023 | +0.99% | +0.55% | View data |
| 4 | 4 Belgium | 926 | 2023 | +2.24% | +2.71% | View data |
| 5 | 5 Austria | 511.2 | 2023 | +5.36% | +6.48% | View data |
